1999
DOI: 10.1099/00207713-49-4-1701
|View full text |Cite
|
Sign up to set email alerts
|

Detection of three different types of ‘Tropheryma whippelii’ directly from clinical specimens by sequencing, single-strand conformation polymorphism (SSCP) analysis and type-specific PCR of their 16S-23S ribosomal intergenic spacer region

Abstract: The 165-235 rDNA intergenic spacer region of organisms identical with or closely related to ' Tropheryma whippelii', the uncultivated causative agent of Whipple's disease, was analysed directly from 38 clinical specimens of 28 patients using a specific nested PCR followed by direct sequencing. As compared to the reference sequence in public databases, two novel ' T. whippelii' spacer types were recognized. In the absence of DNA-DNA hybridization data it is uncertain whether the three types found represent subt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
69
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 57 publications
(74 citation statements)
references
References 16 publications
5
69
0
Order By: Relevance
“…The DNA was extracted using Qiagen (Hilden, Germany) columns (QIAamp tissue kit) as described by the manufacturer. To perform PCR, the 16 to 23S rDNA intergenic spacer region was amplified and sequenced using primers tw3f and tw4f, domain III of the 23S rRNA gene was amplified and sequenced using primers TW23InsF and TW-InsR2, and the rpoB gene was amplified and sequenced using primers TWRPOB.F and TWRPOB.R, as previously described (6,14,16). PCR products were detected by 1% agarose gel electrophoresis analysis and ethidium bromide staining.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The DNA was extracted using Qiagen (Hilden, Germany) columns (QIAamp tissue kit) as described by the manufacturer. To perform PCR, the 16 to 23S rDNA intergenic spacer region was amplified and sequenced using primers tw3f and tw4f, domain III of the 23S rRNA gene was amplified and sequenced using primers TW23InsF and TW-InsR2, and the rpoB gene was amplified and sequenced using primers TWRPOB.F and TWRPOB.R, as previously described (6,14,16). PCR products were detected by 1% agarose gel electrophoresis analysis and ethidium bromide staining.…”
Section: Methodsmentioning
confidence: 99%
“…In 1991, Wilson et al used broad-range primers to amplify bacterial 16S rDNA directly from infected tissue and then determined that this bacterium belongs to the high-GϩC-content, gram-positive bacteria among the class Actinomycetes (36). To date, six genotypes (numbered 1 to 6) of T. whipplei have been described based on sequence variation within the 16 to 23S ribosomal DNA (rDNA) intergenic spacer, and two genotypes (named A and B) have been described based on the 23S rRNA gene (14)(15)(16)25).…”
mentioning
confidence: 99%
“…These taxonomic relationships were recently confirmed by analyses of sequences derived from the actinobacterial insertion in domain III of the 23S rDNA (8) and hsp65 (22). Taxon-specific 16S rDNA primers have since been used to detect the bacterium in patients (28,39) and sewage effluent (17), while sequence analysis of the 16S-23S rDNA spacer was used for the differentiation of strains into three different groups on the basis of their genotypes (9). Two additional genotypes were also subsequently described (18).…”
mentioning
confidence: 99%
“…The diagnosis of Whipple's disease is usually based on the presence of diastase-resistant non-acidfast periodic acid Schiff (PAS)-positive inclusions in macrophages of intestinal biopsies or by electron microscopy showing the trilamellar membrane of T. whipplei (6). Since the sequences of the rRNA genes are known (14,15,22,28), several PCR systems have been developed to identify parts of its 16S ribosomal DNA (rDNA) (2,4,23), of the 16S-23S rDNA internal transcribed spacer (ITS) (12), or of the 23S rDNA (13). These DNA amplification methods are more sensitive than histopathological analysis.…”
mentioning
confidence: 99%